PT Suparma Tbk Statistics

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 885.67 billion. The enterprise value is 1.40 trillion.

Market Cap	885.67B
Enterprise Value	1.40T

Important Dates

The next estimated earnings date is Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

PT Suparma Tbk has 4.10 billion shares outstanding.

Current Share Class	4.10B
Shares Outstanding	4.10B
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.02%
Float	313.67M

Valuation Ratios

The trailing PE ratio is 8.34.

PE Ratio	8.34
Forward PE	n/a
PS Ratio	0.32
PB Ratio	0.36
P/TBV Ratio	0.36
P/FCF Ratio	1.63
P/OCF Ratio	1.51
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.33, with an EV/FCF ratio of 2.58.

EV / Earnings	13.18
EV / Sales	0.51
EV / EBITDA	4.33
EV / EBIT	7.07
EV / FCF	2.58

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.29.

Current Ratio	2.00
Quick Ratio	0.54
Debt / Equity	0.29
Debt / EBITDA	2.20
Debt / FCF	1.31
Interest Coverage	4.95

Financial Efficiency

Return on equity (ROE) is 4.36% and return on invested capital (ROIC) is 5.12%.

Return on Equity (ROE)	4.36%
Return on Assets (ROA)	3.51%
Return on Invested Capital (ROIC)	5.12%
Return on Capital Employed (ROCE)	6.86%
Weighted Average Cost of Capital (WACC)	6.50%
Revenue Per Employee	3.33B
Profits Per Employee	128.92M
Employee Count	824
Asset Turnover	0.78
Inventory Turnover	2.32

Taxes

In the past 12 months, PT Suparma Tbk has paid 30.51 billion in taxes.

Income Tax	30.51B
Effective Tax Rate	22.31%

Stock Price Statistics

The stock price has increased by +4.78% in the last 52 weeks. The beta is 0.72, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+4.78%
50-Day Moving Average	219.56
200-Day Moving Average	234.86
Relative Strength Index (RSI)	47.01
Average Volume (20 Days)	439,855

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.74 trillion and earned 106.23 billion in profits. Earnings per share was 25.91.

Revenue	2.74T
Gross Profit	426.84B
Operating Income	197.90B
Pretax Income	136.74B
Net Income	106.23B
EBITDA	317.99B
EBIT	197.90B
Earnings Per Share (EPS)	25.91

Full Income Statement

Balance Sheet

The company has 198.04 billion in cash and 712.49 billion in debt, giving a net cash position of -514.45 billion or -125.47 per share.

Cash & Cash Equivalents	198.04B
Total Debt	712.49B
Net Cash	-514.45B
Net Cash Per Share	-125.47
Equity (Book Value)	2.49T
Book Value Per Share	607.14
Working Capital	779.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 587.58 billion and capital expenditures -44.85 billion, giving a free cash flow of 542.72 billion.

Operating Cash Flow	587.58B
Capital Expenditures	-44.85B
Depreciation & Amortization	120.09B
Net Borrowing	-603.76B
Free Cash Flow	542.72B
FCF Per Share	132.36

Full Cash Flow Statement

Margins

Gross margin is 15.57%, with operating and profit margins of 7.22% and 3.88%.

Gross Margin	15.57%
Operating Margin	7.22%
Pretax Margin	4.99%
Profit Margin	3.88%
EBITDA Margin	11.60%
EBIT Margin	7.22%
FCF Margin	19.80%

Dividends & Yields

PT Suparma Tbk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	11.99%
FCF Yield	61.28%

Dividend Details

Stock Splits

The last stock split was on November 10, 2025. It was a forward split with a ratio of 1.3.

Last Split Date	Nov 10, 2025
Split Type	Forward
Split Ratio	1.3

Scores

PT Suparma Tbk has an Altman Z-Score of 1.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.98
Piotroski F-Score	6